Operating Income (Loss) of BIOFORCE NANOSCIENCES HOLDINGS, INC. from 30 Sep 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
BIOFORCE NANOSCIENCES HOLDINGS, INC. quarterly and annual Operating Income (Loss) in USD history and change rate from 30 Sep 2017 to 30 Sep 2025.
  • BIOFORCE NANOSCIENCES HOLDINGS, INC. Operating Income (Loss) for the quarter ending 30 Sep 2025 was $115,915, a 5% increase year-over-year.
  • BIOFORCE NANOSCIENCES HOLDINGS, INC. annual Operating Income (Loss) for 2019 was $46,538, a 30% increase from 2018.
  • BIOFORCE NANOSCIENCES HOLDINGS, INC. annual Operating Income (Loss) for 2018 was $66,740, a 113% decline from 2017.
Source SEC data
View on sec.gov
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

BIOFORCE NANOSCIENCES HOLDINGS, INC. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $115,915 +$6,109 +5% 01 Jul 2025 30 Sep 2025 10-Q 19 Nov 2025 2025 Q3
Q2 2025 $122,781 -$8,341 -7.3% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $133,457 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q3 2024 $122,024 01 Jul 2024 30 Sep 2024 10-Q 19 Nov 2025 2025 Q3
Q2 2024 $114,440 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q4 2019 $46,538 $20,170 -$11,576 -135% 01 Oct 2019 31 Dec 2019 10-K/A 09 Mar 2020 2019 FY
Q3 2019 $34,962 $6,334 +$309 +4.7% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $35,271 $7,182 +$20,347 +74% 01 Apr 2019 30 Jun 2019 10-Q 22 Jul 2019 2019 Q2
Q1 2019 $55,618 $12,852 +$11,122 +46% 01 Jan 2019 31 Mar 2019 10-Q 30 Apr 2019 2019 Q1
Q4 2018 $66,740 $8,594 01 Oct 2018 31 Dec 2018 10-K/A 09 Mar 2020 2019 FY
Q3 2018 $6,643 -$4,442 -202% 01 Jul 2018 30 Sep 2018 10-Q 05 Nov 2019 2019 Q3
Q2 2018 $27,529 01 Apr 2018 30 Jun 2018 10-Q 22 Jul 2019 2019 Q2
Q1 2018 $23,974 01 Jan 2018 31 Mar 2018 10-Q 30 Apr 2019 2019 Q1
Q3 2017 $2,201 01 Jul 2017 30 Sep 2017 10-Q 24 Oct 2018 2018 Q3

BIOFORCE NANOSCIENCES HOLDINGS, INC. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2019 $46,538 +$20,202 +30% 01 Jan 2019 31 Dec 2019 10-K/A 09 Mar 2020 2019 FY
2018 $66,740 -$35,479 -113% 01 Jan 2018 31 Dec 2018 10-K/A 09 Mar 2020 2019 FY
2017 $31,261 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.